Clinical Trial for Peanut and Milk Allergy Treatment

A new clinical trial funded by the Natasha Allergy Research Foundation is showing promising results in treating children with peanut and milk allergies using oral immunotherapy. The trial has already helped 139 patients aged two to 23 improve their tolerance to allergens, with plans to expand to more hospitals in the UK. The ultimate goal is to provide a life without the risk of severe allergic reactions.

mRNA Cancer Vaccine Shows Promise in Treating Aggressive Brain Tumours

A new mRNA cancer vaccine has shown promising results in reprogramming the immune system to attack tumours within 48 hours in a human clinical trial. The vaccine is personalized using the patient's own DNA and has the potential to improve treatment for aggressive brain tumours.

mRNA Cancer Vaccine Shows Promise in Treating Aggressive Brain Tumours

A new mRNA cancer vaccine has shown promising results in reprogramming the immune system to attack tumours within 48 hours. The vaccine has been tested in a human clinical trial with positive outcomes, potentially opening new treatment avenues for aggressive brain tumours.

Lenire Device for Treating Tinnitus

The Lenire device has helped reduce tinnitus symptoms for many individuals, including singer and songwriter Victoria Banks. It works by using electrical stimulation of the tongue to shift the brain's attention away from the buzzing noise. While it's not a cure, the device has shown significant improvements for tinnitus sufferers.

Promising Chlamydia Vaccine Trial Results

A promising chlamydia vaccine has shown positive results in an early-stage clinical trial, offering hope for prevention of the common STI.

Breakthrough Therapy Status for LSD Formulation to Treat Generalized Anxiety Disorder

A clinical trial's positive results led to an LSD formulation receiving breakthrough therapy status from the FDA for treating generalized anxiety disorder. The drug by Mind Medicine Inc. showed promising efficacy and safety in phase 2b trials.